Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to demonstrate the safety and pharmacokinetics of Cefazolin 2g for Injection USP and Dextrose Injection USP in the DUPLEX® Drug Delivery System to Cefazolin 1.5g for Injection USP and Dextrose Injection USP in daily doses of 6g in healthy adult subjects for 11 days of administration.
Epistemonikos ID: 4b94215defd3275e21264a694a7d744cc6df860d
First added on: May 05, 2024